Light Chain Bioscience | Novimmune SA Employee Directory

Biotechnology ResearchSwitzerland51-200 Employees

NovImmune has successfully divested EmaCo AG, a newly established company owning emapalumab and related assets to Sobi on 18 July 2019.

NovImmune SA will continue to operate and focus on its bispecific technology and associated programs and will rebrand as:

“Light Chain Bioscience – A brand of Novimmune SA”.

The brand Light Chain Bioscience brings to life the research and development of novel multi-specific antibodies that rely on their light chain for their function.

A key distinctive feature of these multispecific antibodies is their native human structure, making them well tolerated and easy to develop.

Thus far, NovImmune has advanced seven drug candidates to treat a range of conditions. The Company’s pipeline is a balance of preclinical and clinical candidates for validated and novel targets. NovImmune has established a next-generation antibody drug discovery platform that includes novel bispecific antibody drug capabilities - the simple, stable and smart kappa-lambda-body™. 

In 2009, NovImmune received the European Biotechnica Award. In 2010, NovImmune entered a partnership with Genentech to advance the Company’s anti-IL17 drug candidate. In addition to pursuing additional drug discovery, development and commercialization partnerships, the Company plans to bring selected drugs to market for focused applications.

Find Light Chain Bioscience | Novimmune SA employees' phone numbers or email addresses

Light Chain Bioscience | Novimmune SA Global Highlights

Location
Employees

Europe
77

Minus sign iconPlus sign icon
  • Switzerland
    61
  • France
    14
  • Italy
    1
  • United Kingdom Of Great Britain And Northern Ireland
    1

Light Chain Bioscience | Novimmune SA's Leadership

  • Stylized image of a person
    N. F.
    Chief Executive Officer
    Phone icon
  • Stylized image of a person
    J. B.
    Ceo
    Phone icon
  • Stylized image of a person
    O. E.
    Coo And Cfo
    Phone icon
  • Stylized image of a person
    Y. P.
    Head Of Bioprocessing Unit
    Phone icon
  • Stylized image of a person
    W. F.
    Head Of Exploratory Science & Translational Medicine Department
    Phone icon
  • Stylized image of a person
    N. B.
    Head Of It
    Phone icon
  • Stylized image of a person
    F. B.
    Bioprocessing Unit Head
    Phone icon
  • Stylized image of a person
    K. M.
    Director, Drug Discovery
    Phone icon

Contact profiles from Light Chain Bioscience | Novimmune SA

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    D. T.
    Research Associate
    Phone icon
    SwitzerlandVaud
    Nov 12, 2025
  • Stylized image of a person
    J. B.
    Engineer In Development Of Bispecific Antibodies
    Phone icon
    SwitzerlandGeneva
    Nov 12, 2025
  • Stylized image of a person
    J. M.
    Associate Clinical Scientist
    Phone icon
    SwitzerlandVaud
    Jul 18, 2025
  • Stylized image of a person
    P. L.
    Research Assistant
    Phone icon
    France
    Aug 08, 2025
  • Stylized image of a person
    F. C.
    Research Associate
    Phone icon
    Switzerland
    Nov 12, 2025
  • Stylized image of a person
    L. B.
    Research Associate In The Assay Development Unit
    Phone icon
    SwitzerlandGeneva
    Nov 12, 2025
  • Stylized image of a person
    A. V.
    Research Assistant
    Phone icon
    FranceAuvergne-Rhône-Alpes
    Aug 08, 2025
  • Stylized image of a person
    N. B.
    Research Associate
    Phone icon
    Nov 12, 2025
  • Stylized image of a person
    L. C.
    Research Associate
    Phone icon
    SwitzerlandGeneva
    Nov 12, 2025
  • Stylized image of a person
    F. J.
    Project Coordinator
    Phone icon
    Aug 07, 2025

Frequently Asked Questions

What is Light Chain Bioscience | Novimmune SA known for?

Minus sign iconPlus sign icon
Light Chain Bioscience | Novimmune SA was founded in 1998 operates in the Biotechnology Research industry. The company's main headquarters is located in Chemin du Pré-Fleuri 15, 3ième Étage Plan-les-Ouates, Genève 1228, CH; you can contact the main corporate office by phone at . Explore Light Chain Bioscience | Novimmune SA's company overview page for more information.

What is Light Chain Bioscience | Novimmune SA's most common email format?

Minus sign iconPlus sign icon
Light Chain Bioscience | Novimmune SA employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Light Chain Bioscience | Novimmune SA email formats with LeadIQ.

How many employees does Light Chain Bioscience | Novimmune SA have currently?

Minus sign iconPlus sign icon
Light Chain Bioscience | Novimmune SA has approximately 77 employees as of October 2025. These team members are located across 1 continents, including Europe.

Who are Light Chain Bioscience | Novimmune SA's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2025, Light Chain Bioscience | Novimmune SA's key employees include:

  • Chief Executive Officer: N. F.
  • Ceo: J. B.
  • Coo And Cfo: O. E.
  • Head Of Bioprocessing Unit: Y. P.
  • Head Of Exploratory Science & Translational Medicine Department: W. F.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.